From the Editor-in-Chief: The Way Up
Building a Patient-Centered Cancer Center From the Ground Up
Addressing Disparities in Cancer Care and Beyond: What Can Be Done Now?
Dr David S. Hong: We Are Learning Every Day About Cellular Therapies
Conversations on CAR T: Study of Checkpoint Inhibitors After Transplant Bolsters Case for CAR T, Skarbnik Says
Conversations on CAR T: UAB’s Mehta Discusses Opportunities and Challenges
The Promise of Liquid Biopsies for Cancer Diagnosis
Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says
Abstracts at ASCO Quality Show Uptake of Rapid NGS, Biomarker Testing Across OneOncology
